Intelligence Platform

Patents

Browse 822 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 7138137

Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparatio

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7112341

Pulmonary administration of dry powder formulations for treating infertility

Nektar Therapeutics · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7109323

Formulation of boronic acid compounds

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7087723

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7060672

Cyclosporin analog formulations

Isotechnika, Inc. · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6984402

Chrono delivery formulations and method of treating atrial fibrillation

Elite Laboratories, Inc. · Granted Tue Jan 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6958319

Formulation of boronic acid compounds

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6949255

Inhibitory chemical formulation with preservative system

The Board of Regents of the University of Texas · Granted Tue Sep 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6943027

Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo d

The Regents of the University of California · Granted Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6926909

Chrono delivery formulations and method of use thereof

Elite Laboratories, Inc. · Granted Tue Aug 09 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6896909

Formulations containing iron ores for the topical treatment of bioenergetic and electromag

WINMEDICAL S.R.L. · Granted Tue May 24 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6846809

PEI: DNA vector formulations for in vitro and in vivo gene delivery

The Board of Regents of the University of Texas System · Granted Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6844004

Topical formulations of natamycin/pimaricin

The Board of Regents of the University of Texas System · Granted Tue Jan 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6713446

Formulation of boronic acid compounds

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6699835

Formulation of boronic acid compounds

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6676941

Antibody conjugate formulations for selectively inhibiting VEGF

The Board of Regents of the University of Texas System · Granted Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6589560

Stable glassy state powder formulations

Nektar Therapeutics · Granted Tue Jul 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6586573

Albumin-free Factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Tue Jul 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6569459

Method of administration of paclitaxel-plasma protein formulation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 27 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6555127

Multi-spike release formulation for oral drug delivery

Pharmaceutical Discovery Corporation · Granted Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6482417

Stable pharmaceutical formulation comprising torsemide modification II

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6410049

Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo d

The Regents of the University of California · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6399087

Propofol formulation with enhanced microbial inhibition

Amphastar Pharmaceuticals, Inc. · Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6319904

Formulation comprising antibacterial substance and antiulcer substance

Takeda Chemical Industries Ltd. · Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)